La découverte des sulfamides hypoglycémiants
J. Soc. Biol., 201 2 (2007) 121-125
Published online: 2008-01-01
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Characterization of four structurally diverse inhibitors of SUR2-containing K ATP channels
Kangjun Li, Vaishali Satpute Janve and Jerod DentonChannels 18 (1) (2024)
https://doi.org/10.1080/19336950.2024.2398565
Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B KATP Channels
Kangjun Li, Samantha J. McClenahan, Changho Han, Joseph D. Bungard, Upendra Rathnayake, Olivier Boutaud, Joshua A. Bauer, Emily L. Days, Craig W. Lindsley, Elaine L. Shelton and Jerod S. DentonMolecular Pharmacology 105 (3) 202 (2024)
https://doi.org/10.1124/molpharm.123.000783
Xanthene Derivatives Targeting Bacterial Efflux Pumps, Quorum-Sensing, and Biofilm Formation
Miguel Maia, Fernando Durães, Diana I. S. P. Resende, Nikoletta Szemerédi, Luís Gales, Paulo Martins-da-Costa, Madalena Pinto, Gabriella Spengler and Emília SousaDrugs and Drug Candidates 1 (1) 29 (2022)
https://doi.org/10.3390/ddc1010004
Bioactive fluorenes. Part IV: Design, synthesis, and a combined in vitro, in silico anticancer and antibacterial evaluation of new fluorene-heterocyclic sulfonamide conjugates
Essam M. Hussein, M. Shaheer Malik, Reem I. Alsantali, Basim H. Asghar, Moataz Morad, Mohammad Azam Ansari, Qazi Mohammad Sajid Jamal, Abdulrahman A. Alsimaree, Ashraf N. Abdalla, Alanood S. Algarni, Rabab S. Jassas, Hatem M. Altass and Saleh A. AhmedJournal of Molecular Structure 1246 131232 (2021)
https://doi.org/10.1016/j.molstruc.2021.131232
In a cohort of individuals with type 2 diabetes using the drug sulfasalazine, HbA1c lowering is associated with haematological changes
Samira M. S. N’Dow, Louise A. Donnelly, Ewan R. Pearson and Graham RenaDiabetic Medicine 38 (9) (2021)
https://doi.org/10.1111/dme.14463
The discovery of hypoglycaemic sulphonamides – Montpellier, 1942
Thierry Lavabre-Bertrand and Jean-Luc FaillieTherapies 76 (6) 559 (2021)
https://doi.org/10.1016/j.therap.2021.09.003
Sulfonylureas for Treatment of Periodontitis-Diabetes Comorbidity-Related Complications: Killing Two Birds With One Stone
Luxi Yang, Qing Ge, Zhitong Ye, et al.Frontiers in Pharmacology 12 (2021)
https://doi.org/10.3389/fphar.2021.728458
Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?
Axel DalhoffInfection 49 (1) 29 (2021)
https://doi.org/10.1007/s15010-020-01536-y
Solvent and temperature effects on the solubility of some new adamantane/memantine sulfonamide derivatives
German L. Perlovich, Tatyana V. Volkova, Nadezda N. Strakhova and Vladimir P. KazachenkoJournal of Molecular Liquids 342 117489 (2021)
https://doi.org/10.1016/j.molliq.2021.117489
The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy—A Review
Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, Katarzyna Gontarz-Nowak, Ewa Gątarska and Elżbieta Bandurska-StankiewiczJournal of Clinical Medicine 10 (4) 705 (2021)
https://doi.org/10.3390/jcm10040705
Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies
Zuhal Alım, Zeynep Köksal and Muhammet KaramanPharmacological Reports 72 (6) 1738 (2020)
https://doi.org/10.1007/s43440-020-00149-4
Pyrrolo and pyrrolopyrimidine sulfonamides act as cytotoxic agents in hypoxia via inhibition of transmembrane carbonic anhydrases
Omneya M. Khalil, Aliaa M. Kamal, Silvia Bua, Heba El Sayed Teba, Yassin M. Nissan and Claudiu T. SupuranEuropean Journal of Medicinal Chemistry 188 112021 (2020)
https://doi.org/10.1016/j.ejmech.2019.112021
A high-throughput chemical–genetics screen in murine adipocytes identifies insulin-regulatory pathways
Paul Duffield Brewer, Irina Romenskaia and Cynthia Corley MastickJournal of Biological Chemistry 294 (11) 4103 (2019)
https://doi.org/10.1074/jbc.RA118.006986
Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063
Sujay V. Kharade, Juan Vicente Sanchez-Andres, Mark G. Fulton, Elaine L. Shelton, Anna L. Blobaum, Darren W. Engers, Christopher S. Hofmann, Prasanna K. Dadi, Louise Lantier, David A. Jacobson, Craig W. Lindsley and Jerod S. DentonThe Journal of Pharmacology and Experimental Therapeutics 370 (3) 350 (2019)
https://doi.org/10.1124/jpet.119.257204
Mechanism of action of camphoryl‐benzene sulfonamide derivative on glucose uptake in adipose tissue
Marisa J. S. Frederico, Allisson J. G. Castro, Veronica A. M. Pinto, Cristiane D. F. Ramos, Fabíola B. F. Monteiro, Alessandra Mascarello, Ricardo J. Nunes and Fátima R. M. B. SilvaJournal of Cellular Biochemistry 119 (6) 4408 (2018)
https://doi.org/10.1002/jcb.26506
The shifting landscape of KATPchannelopathies and the need for ‘sharper’ therapeutics
Sujay V Kharade, Colin Nichols and Jerod S DentonFuture Medicinal Chemistry 8 (7) 789 (2016)
https://doi.org/10.4155/fmc-2016-0005
Development of a novel carbon paste sensor for determination of micromolar amounts of sulfaquinoxaline in pharmaceutical and biological samples
Ahmad Soleymanpour and Seyyed Ahmad RezvaniMaterials Science and Engineering: C 58 504 (2016)
https://doi.org/10.1016/j.msec.2015.08.034
A green approach for the synthesis of bis (substituted sulfabenzamide) para-benzoquinone based on the reaction of sulfabenzamide with electrochemically generated para-benzoquinone and its antibacterial evaluation
Sadegh Khazalpour, Davood Nematollahi and Mohammad Reza Pajohi-AlamotiNew Journal of Chemistry 39 (9) 6734 (2015)
https://doi.org/10.1039/C5NJ01314C
Antidiabétiques oraux dans le traitement du diabète de type 2 : perspectives historique et médico-économique
A.-J. ScheenMédecine des Maladies Métaboliques 9 (2) 186 (2015)
https://doi.org/10.1016/S1957-2557(15)30042-0
615 (2015)
https://doi.org/10.1002/9781118387658.ch42
Cardiovascular impact of drugs used in the treatment of diabetes
Chris R. Triggle and Hong DingTherapeutic Advances in Chronic Disease 5 (6) 245 (2014)
https://doi.org/10.1177/2040622314546125
Auguste Loubatières : l’histoire des sulfamides hypoglycémiants
L. MonnierMédecine des Maladies Métaboliques 8 (1) 107 (2014)
https://doi.org/10.1016/S1957-2557(14)70697-2
Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide
Fatemeh Bagheri, Shahrokh Safarian, Mohamadreza Baghaban Eslaminejad and Nader SheibaniMolecular Biology Reports 41 (11) 7387 (2014)
https://doi.org/10.1007/s11033-014-3626-3
The behavior of Gliclazide in solution and in the solid state: a case of organic compound presenting a solid‐solution structure
Dolores Santa María, Rosa M. Claramunt, Ibon Alkorta and José ElgueroMagnetic Resonance in Chemistry 47 (6) 472 (2009)
https://doi.org/10.1002/mrc.2414